UK to identify barriers to commercialisation of regenerative medicines
This article was originally published in RAJ Devices
Executive Summary
The UK government has launched a stock-taking exercise to gauge the latest developments in the field of regenerative medicine1. The aim is to identify barriers to commercialisation and clinical application and assess what actions the National Health Service should take to prepare for new treatments.